Advanced Medical Solutions (LSE:AMS) expects to report first-half 2026 revenue of approximately £115.2 million, compared with £110.8 million in the same period last year. The increase comes despite some customer orders being delayed into July and temporary de-stocking associated with the company’s strategy to expand its direct sales operations across Europe. The performance also follows a strong comparative period for the Advanced Closure division. Despite these factors, the board remains confident that full-year EBITDA will meet current market expectations.
The company said integration of the Peters Surgical and Syntacoll acquisitions is continuing as planned, supporting its strategy of expanding its portfolio of surgical products while delivering operational and commercial synergies. Management believes the enlarged product offering and healthy pipeline of growth opportunities position the business to deliver scalable expansion, improved margins and long-term value creation.
Advanced Medical Solutions has shown improving revenue and cash flow in recent trading, although profitability remains below previous peak levels and leverage has increased following recent acquisitions. Technical indicators remain positive, reflecting a strong share price trend, although momentum appears stretched. Valuation remains relatively demanding, with a high price-to-earnings ratio and a modest dividend yield.
More about Advanced Medical Solutions
Advanced Medical Solutions Group plc is a UK-based medical technology company that develops and manufactures products for tissue healing, surgical procedures and advanced wound care. Its portfolio includes surgical adhesives, sealants, sutures and biosurgical products used by healthcare professionals around the world.
The company is expanding its international presence through acquisitions and investment in direct sales capabilities, particularly following the acquisition of Peters Surgical. By combining advanced biomaterial technologies with an expanding commercial platform, Advanced Medical Solutions aims to strengthen its position in the global surgical and wound care markets.
Leave a Reply